Jason Silvers insider trades: Generate Biomedicines (GENB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jason reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | GENB | ↑ Buy | 1,000 | $16.00 | $16K | By son | Mar 2, 2026 (0d) |
| Mar 2, 2026 | GENB | ↑ Buy | 500 | $16.00 | $8K | By daughter | Mar 2, 2026 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GENB insiders
Open-market trades in the last 12 months
About Jason Silvers's insider trades
Jason Silvers is President & CFO at Generate Biomedicines (GENB). Since Mar 2, 2026, Jason has reported 2 open-market purchases worth $24K and no sales on SEC Form 4. In the last 12 months: 2 buys ($24K).
Their filings also include grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GENB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.